Catalyst Wire Dossier Catalyst Wire Dossier

hESC-derived retinal pigment epithelium cells

human embryonic stem cell-derived retinal pigment epithelium cells · Astellas Institute for Regenerative Medicine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for hESC-derived retinal pigment epithelium cells, covering 2024-10-31 to 2024-10-31. Get the full timeline:

Most recent: Clinical Trial Update: Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD

See pricing